Timurhan Cebeci

Timurhan Cebeci

Auto-generated profile, based on publicly available information

Timurhan Cebeci

The Medical Faculty of Istanbul University, Department of Internal Medicine, Division of General Internal Medicine, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2022 in Experimental Gerontology
Verified
Journal Article
Open access
NSNaci Senkal
Naci Senkal
Gülistan BahatGülistan Bahat
Gülistan Bahat
AMAlpay Medetalibeyoglu
Alpay Medetalibeyoglu
TCTimurhan Cebeci
Timurhan Cebeci
DDDilek Deniz
Dilek Deniz
TTTufan Tukek
Tufan Tukek
While the definitive diagnosis of COVID-19 relies on PCR confirmation of the virus, the sensitivity of this technique is limited. The clinicians had to go on with the clinical diagnosis of COVID-19 in selected cases. We aimed to compare PCR-positive and PCR-negative patients diagnosed as COVID-19 with a specific focus on older adults. We studied 601 hospitalized adults. The demographics, co-morbidities, triage clinical, laboratory characteristics, and outcomes were noted. Differences between the PCR (+) and (−) cases were analyzed. An additional specific analysis focusing on older adults (≥65 years) (n = 184) was performed. The PCR confirmation was present in 359 (59.7 %). There was not any difference in terms of age, sex, travel/contact history, hospitalization duration, ICU need, the time between first symptom/hospitalization to ICU need, ICU days, or survival between PCR-positive and negative cases in the total study group and older adults subgroup. The only symptoms that were different in prevalence between PCR-confirmed and unconfirmed cases were fever (73.3 % vs. 64 %, p = 0.02) and fatigue/myalgia (91.1 % vs. 79.3 %, p = 0.001). Bilateral diffuse pneumonia was also more prevalent in PCR-confirmed cases (20 % vs. 13.3 %, p = 0.03). In older adults, the PCR (−) cases had more prevalent dyspnea (72.2 % vs. 51.4 %, p = 0.004), less prevalent fatigue/myalgia (70.9 % vs. 88.6 %, p = 0.002). The PCR (+) and (−) cases displayed very similar disease phenotypes, courses, and outcomes with few differences between each other. The presence of some worse laboratory findings may indicate a worse immune protective response in PCR (−) cases.